Immunology + Inflammation

Immunology sheds light on the body's responses to foreign organisms, such as viruses, bacteria, protozoa, and parasites. Researchers in SRI's Center for Autoimmune and Inflammatory Diseases develop therapeutics that manipulate immune responses, and work toward immunology drug development to treat autoimmune and infectious diseases and cancer.

The group's immunology research focuses on the roles of cells and soluble factors in regulating immunity and the transition to adaptive immune responses. Immunological assays are directed toward understanding the mechanisms of activation of dendritic cells, which are critical for the induction of primary immune responses.

To meet clients' needs at all stages of immunology drug discovery and preclinical development, SRI provides a range of immunology services, including:

Projects

monoclonal antibodies

Novel molecular targets of several cytokines are being evaluated by SRI scientists, with the goal of designing a small-molecule drug to block responses involved in many of these inflammatory diseases.

Press Releases

Researchers at SRI are developing a new Multiple Sclerosis drug that can be taken by mouth. It will be more convenient than current treatments, which require frequent hospital visits for injections or intravenous infusions.

SRI In the News

Gel Developed in Menlo Park Could Help Prevent HIV, HSV-2

SRI Biosciences is developing a long-lasting, two-part microbicide gel to protect women from HIV and HSV infections—and the delivery system puts the technology in the hands of women themselves.